BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23055733)

  • 21. Poly(N,N-dimethylacrylamide)-coated maghemite nanoparticles for stem cell labeling.
    Babic M; Horák D; Jendelová P; Glogarová K; Herynek V; Trchova M; Likavanová K; Lesný P; Pollert E; Hájek M; Syková E
    Bioconjug Chem; 2009 Feb; 20(2):283-94. PubMed ID: 19238690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical states in XPS and Raman analysis during removal of Cr(VI) from contaminated water by mixed maghemite-magnetite nanoparticles.
    Chowdhury SR; Yanful EK; Pratt AR
    J Hazard Mater; 2012 Oct; 235-236():246-56. PubMed ID: 22902142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
    Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
    Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A filamentous bacteriophage targeted to carcinoembryonic antigen induces tumor regression in mouse models of colorectal cancer.
    Murgas P; Bustamante N; Araya N; Cruz-Gómez S; Durán E; Gaete D; Oyarce C; López E; Herrada AA; Ferreira N; Pieringer H; Lladser A
    Cancer Immunol Immunother; 2018 Feb; 67(2):183-193. PubMed ID: 29026949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Carcinoembryonic-Antigen-(CEA)-Specific Pretargeting System to Assess Tumor Cell Viability after Irradiation of Colorectal Cancer Cells.
    Meller B; Rave-Fränck M; Breunig C; Schirmer M; Baehre M; Nadrowitz R; Liersch T; Meller J
    Strahlenther Onkol; 2011 Feb; 187(2):120-6. PubMed ID: 21271227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of CEA in human serum using surface-enhanced Raman spectroscopy coupled with antibody-modified Au and γ-Fe₂O₃@Au nanoparticles.
    Lin Y; Xu G; Wei F; Zhang A; Yang J; Hu Q
    J Pharm Biomed Anal; 2016 Mar; 121():135-140. PubMed ID: 26808062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and
    Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
    World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-gamma.
    Guadagni F; Witt PL; Robbins PF; Schlom J; Greiner JW
    Cancer Res; 1990 Oct; 50(19):6248-55. PubMed ID: 2119252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticles functionalized with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells.
    Vigor KL; Kyrtatos PG; Minogue S; Al-Jamal KT; Kogelberg H; Tolner B; Kostarelos K; Begent RH; Pankhurst QA; Lythgoe MF; Chester KA
    Biomaterials; 2010 Feb; 31(6):1307-15. PubMed ID: 19889453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
    Foon KA; John WJ; Chakraborty M; Sherratt A; Garrison J; Flett M; Bhattacharya-Chatterjee M
    Clin Cancer Res; 1997 Aug; 3(8):1267-76. PubMed ID: 9815809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Target mediated disposition of T84.66, a monoclonal anti-CEA antibody: application in the detection of colorectal cancer xenografts.
    Urva SR; Balthasar JP
    MAbs; 2010; 2(1):67-72. PubMed ID: 20081377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours.
    Durrant LG; Denton GW; Jacobs E; Mee M; Moss R; Austin EB; Baldwin RW; Hardcastle JD; Robins RA
    Int J Cancer; 1992 Mar; 50(5):811-6. PubMed ID: 1544714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of antibody functionalized magnetic nanoparticles for the immunoassay of carcinoembryonic antigen: a feasibility study for clinical use.
    Yang CC; Yang SY; Ho CS; Chang JF; Liu BH; Huang KW
    J Nanobiotechnology; 2014 Nov; 12():44. PubMed ID: 25424410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visualization of custom-tailored iron oxide nanoparticles chemistry, uptake, and toxicity.
    Wilkinson K; Ekstrand-Hammarström B; Ahlinder L; Guldevall K; Pazik R; Kępiński L; Kvashnina KO; Butorin SM; Brismar H; Önfelt B; Österlund L; Seisenbaeva GA; Kessler VG
    Nanoscale; 2012 Dec; 4(23):7383-93. PubMed ID: 23070150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel flow cytometric analysis of the progress and route of internalization of a monoclonal anti-carcinoembryonic antigen (CEA) antibody.
    Ford CH; Tsaltas GC; Osborne PA; Addetia K
    Cytometry; 1996 Mar; 23(3):228-40. PubMed ID: 8974868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectroscopic study of maghemite nanoparticles surface-grafted with DMSA.
    Soler MA; Lima EC; Nunes ES; Silva FL; Oliveira AC; Azevedo RB; Morais PC
    J Phys Chem A; 2011 Feb; 115(6):1003-8. PubMed ID: 21261312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of Iron oxide nanoparticles using Mössbauer spectroscopy with a high velocity resolution.
    Oshtrakh MI; Ushakov MV; Šepelák V; Semionkin VA; Morais PC
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 152():666-79. PubMed ID: 26105556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photoacoustic investigation of maghemite-based nanocomposite.
    Rodriguez AF; Gilhermitti MF; Faria FS; Cunha RM; Santos JG; Oliveira AC; Morales MA; Rabelo D; Azevedo RB; Morais PC
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Jan; 100():72-4. PubMed ID: 22483383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular composition of iron oxide nanoparticles, precursors for magnetic drug targeting, as characterized by confocal Raman microspectroscopy.
    Chourpa I; Douziech-Eyrolles L; Ngaboni-Okassa L; Fouquenet JF; Cohen-Jonathan S; Soucé M; Marchais H; Dubois P
    Analyst; 2005 Oct; 130(10):1395-403. PubMed ID: 16172665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering of stealth (maghemite/PLGA)/chitosan (core/shell)/shell nanocomposites with potential applications for combined MRI and hyperthermia against cancer.
    Fernández-Álvarez F; Caro C; García-García G; García-Martín ML; Arias JL
    J Mater Chem B; 2021 Jun; 9(24):4963-4980. PubMed ID: 34114575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.